Seres Therapeutics (MCRB) PT Raised to $32.50 at Chardan Capital Markets
Tweet Send to a Friend
Chardan Capital Markets analyst Taylor Feehley raised the price target on Seres Therapeutics (NASDAQ: MCRB) to $32.50 (from $12.50) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
